CN Patent

CN104725349A — 阿格列汀盐酸盐多晶a型晶体、其制备方法及生产用途

Assigned to HUBEI WATERSTONE BIO-PHARMACEUTICAL TECHNOLOGY Co Ltd · Expires 2015-06-24 · 11y expired

What this patent protects

本发明公开了阿格列汀盐酸盐多晶A型晶体和其制备方法。所得晶体能以高纯度从体系中析出，并有效的去除反应中的二聚副产物，提高生产效率，降低生产成本。多晶A型晶体为无水四氢呋喃溶剂化合物，其稳定性好，方便贮存和运输。

USPTO Abstract

本发明公开了阿格列汀盐酸盐多晶A型晶体和其制备方法。所得晶体能以高纯度从体系中析出，并有效的去除反应中的二聚副产物，提高生产效率，降低生产成本。多晶A型晶体为无水四氢呋喃溶剂化合物，其稳定性好，方便贮存和运输。

Drugs covered by this patent

Patent Metadata

Patent number: CN104725349A
Jurisdiction: CN
Classification: —
Expires: 2015-06-24
Drug substance claim: No
Drug product claim: No
Assignee: HUBEI WATERSTONE BIO-PHARMACEUTICAL TECHNOLOGY Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.